Industry Goes On Offensive Against Prescription Pseudoephedrine Trend
This article was originally published in The Tan Sheet
Executive Summary
Drug firms hope to dissuade states from moving drugs that contain methamphetamine precursors to prescription status by funding electronic systems to track nonprescription sales of the products